Equipment and Processing Report, Apr 18, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Equipment and Processing Report, Apr 18, 2012
Production Lines
Achieving Containment in High-Potency Manufacturing
By Jennifer Markarian
The growing use of high-potency APIs is leading to changes in how the pharmaceutical industry looks at containment.
In the Mixer
Blow–Fill–Seal Technology Meets Challenges of Sterile Packaging
By Ken Muhvich , Hal Baseman
Using blow–fill–seal technology to form and fill a plastic container in a continuous process addresses sterile packaging issues such as package defects, contamination, and process validation.
Troubleshooting
Maintaining Data Continuity When Networks Fail
My network failed and I had to scrap my batch because my historian did not collect the required data. How do I upgrade the reliability of my network to maintain data continuity if my network fails again?
Editor's Picks
April 2012 Editor's Picks: Products from AdvantaPure and Fitzpatrick Company
PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the April 2012 edition from AdvantaPure and Fitzpatrick Company.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here